1-9 of 9
Dongho Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Discontinuation of Imatinib Therapy in Chronic Myeloid Leukemia Patients with Sustained Complete Molecular Response 4.5 (CMR 4.5 )

Hyun-Gyung Goh, Soo-Young Choi, Ju-Hee Bang, Soo-Hyun Kim, Eun-Jung Jang, Dongho Kim, Ji-Young Byeun, Joon Seong Park, Hyeoung-Joon Kim, Hawk Kim, Dong-Wook Kim
Journal: Blood
Blood (2011) 118 (21): 2763.
https://doi.org/10.1182/blood.V118.21.2763.2763
Published: 2011
Journal Articles

Efficacy of Nilotinib Versus High-Dose Imatinib in Early Chronic Phase CML Patients Who Have Suboptimal Molecular Responses to Standard-Dose Imatinib (RE-NICE Multicenter Study)

Hyun-Gyung Goh, Saengsuree Jootar, Hyeoung-Joon Kim, Sang Kyun Sohn, Joon Seong Park, Sung Hyun Kim, Dae Young Zang, Suk-Joong Oh, Soo-Young Choi, Ju-Hee Bang, Soo-Hyun Kim, Eun-Jung Jang, Sung-Eun Lee, Dongho Kim, Ji-Young Byeun, Richard C. Woodman, Tomasz Szczudlo, Hee Jung Kim, Dong-Wook Kim
Journal: Blood
Blood (2011) 118 (21): 2765.
https://doi.org/10.1182/blood.V118.21.2765.2765
Published: 2011
Journal Articles

Correlation of Molecular Response At 18 Month with Survival Benefits As Response-Related Prognostic Factor

Soo-Hyun Kim, Dongho Kim, Hyun-Gyung Goh, Soo-Young Choi, Ju-Hee Bang, Ji-Young Byeun, Dong-Wook Kim
Journal: Blood
Blood (2011) 118 (21): 2766.
https://doi.org/10.1182/blood.V118.21.2766.2766
Published: 2011
Journal Articles

Mutation Analysis of BCR-ABL Tyrosine Kinase Domain In New Chronic Phase-Chronic Myeloid Leukemia Patients with Suboptimal Response or Treatment Failure From Imatinib Treatment.

Dong-Wook Kim, MD, Dongho Kim, Soo-Hyun Kim, Hyun-Gyung Goh, Fabrizio Pane, Timothy Hughes, Jerald P. Radich, Peter Lin, Giuseppe Saglio, Susan Branford, Giovanni Martinelli, Simona Soverini, Andreas Hochhaus
Journal: Blood
Blood (2010) 116 (21): 3441.
https://doi.org/10.1182/blood.V116.21.3441.3441
Published: 2010
Journal Articles

Dynamics and Characteristics of BCR-ABL Multiple Mutations In Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia.

Dong-Wook Kim, Dongho Kim, Soo-Hyun Kim, Saengsuree Jootar, Hyun-Gyung Goh, Jeong Lee, Soo-Young Choi, Young-Seok Lee, Sang-Mi Oh
Journal: Blood
Blood (2010) 116 (21): 3443.
https://doi.org/10.1182/blood.V116.21.3443.3443
Published: 2010
Journal Articles

Monitoring of Dynamics of BCR-ABL Transcripts Over Time Using Digital PCR Assay In CP CML Patients After Achieving Complete Molecular Remission

Hyun-Gyung Goh, Dongho Kim, Soo-Young Choi, Soo-Hyun Kim, Jeong Lee, Young-Seok Lee, Sang-Mi Oh, Dong-Wook Kim, MD
Journal: Blood
Blood (2010) 116 (21): 1726.
https://doi.org/10.1182/blood.V116.21.1726.1726
Published: 2010
Journal Articles

Impact of Baseline BCR-ABL Transcript Levels on the Response to Imatinib In CP CML Patients

Hyun-Gyung Goh, Dongho Kim, Soo-Young Choi, Soo-Hyun Kim, Jeong Lee, Young-Seok Lee, Sang-Mi Oh, Dong-Wook Kim, MD
Journal: Blood
Blood (2010) 116 (21): 1240.
https://doi.org/10.1182/blood.V116.21.1240.1240
Published: 2010
Journal Articles

Pleural Effusion in Dasatinib-Treated Chronic Myeloid Leukemia Patients after Imatinib Failure

Dongho Kim, PhD, Il-Young Kweon, Sa-Hee Park, Ji-Sun Lim, Hey-Sun Chung, Ha-Na Kim, Harriet Goh, Soo-Hyun Kim, Jung Lee, Won- Seok Kim, PhD, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4270.
https://doi.org/10.1182/blood.V112.11.4270.4270
Published: 2008
Journal Articles

Clinical Characteristics and Outcome of 20 Imatinib Mesylate Resistant Patients with T315I BCR-ABL Mutation.

Wan-Seok Kim, PhD, Il-Young Kweon, Soo Hyun Kim, Hyun Gyung Goh, Jeong Lee, Se Eun Jung, Dongho Kim, PhD, Sa-Hee Park, Ji-Sun Lim, Ha-Na Kim, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1954.
https://doi.org/10.1182/blood.V110.11.1954.1954
Published: 2007